Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target GFRA3 (clone HE9Q2ES). We employs the Retrovirus (EF1α-GFP-c-Fos-XbaI) vector components and the SynExpress system of the Histone modification sites RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
GFRA3
Clone
HE9Q2ES
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
c-Fos
Insertion Sites
XbaI
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
Retrovirus
Transformation Accuracy
0.91
Cell Culture
Adherent Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.